These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28296661)

  • 1. Causal Mediation Analysis of Survival Outcome with Multiple Mediators.
    Huang YT; Yang HI
    Epidemiology; 2017 May; 28(3):370-378. PubMed ID: 28296661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediation analysis with causally ordered mediators using Cox proportional hazards model.
    Cho SH; Huang YT
    Stat Med; 2019 Apr; 38(9):1566-1581. PubMed ID: 30565274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediation analysis for survival data using semiparametric probit models.
    Huang YT; Cai T
    Biometrics; 2016 Jun; 72(2):563-74. PubMed ID: 26618735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediation effect of hepatitis B and C on mortality.
    Huang YT; Freeman JR; Yang HI; Liu J; Lee MH; Chen CJ
    Eur J Epidemiol; 2016 Jun; 31(6):625-33. PubMed ID: 26792787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBV viral load is an independent predictor of progression to hepatocellular carcinoma in chronic HBV patients.
    Aboulhab J
    Euro Surveill; 2006 Jan; 11(1):E060126.6. PubMed ID: 16801717
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
    Chen CL; Yang HI; Yang WS; Liu CJ; Chen PJ; You SL; Wang LY; Sun CA; Lu SN; Chen DS; Chen CJ
    Gastroenterology; 2008 Jul; 135(1):111-21. PubMed ID: 18505690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival mediation analysis with the death-truncated mediator: The completeness of the survival mediation parameter.
    Tai AS; Tsai CA; Lin SH
    Stat Med; 2021 Jul; 40(17):3953-3974. PubMed ID: 34111901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
    Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history: the importance of viral load, liver damage and HCC.
    Wursthorn K; Manns MP; Wedemeyer H
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1063-79. PubMed ID: 19187867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk.
    Huang YT; Yang HI; Liu J; Lee MH; Freeman JR; Chen CJ
    Epidemiology; 2016 Jan; 27(1):14-20. PubMed ID: 26443934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.
    Kim GA; Han S; Kim HD; An J; Lim YS
    J Viral Hepat; 2017 Nov; 24(11):990-997. PubMed ID: 28499070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Hepatology; 2012 Jan; 55(1):68-76. PubMed ID: 21858846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV).
    Pan WC; Wu CD; Chen MJ; Huang YT; Chen CJ; Su HJ; Yang HI
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26561636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
    Lai MS; Hsieh MS; Chiu YH; Chen TH
    Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antiviral treatment on the risk of hepatocellular cancer in patients with chronic viral hepatitis.
    Stournaras E; Neokosmidis G; Stogiannou D; Protopapas A; Tziomalos K
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1277-1282. PubMed ID: 30179906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.
    Tanaka H; Tsukuma H; Kasahara A; Hayashi N; Yoshihara H; Masuzawa M; Kanda T; Kashiwagi T; Inoue A; Kato M; Oshima A; Kinoshita Y; Kamada T
    Int J Cancer; 2000 Sep; 87(5):741-9. PubMed ID: 10925370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What can we learn from hepatitis B virus clinical cohorts?
    Lin CL; Tseng TC; Kao JH
    Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.